EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Hemodialysis Patients with COVID-19: A Retrospective Observational Study

Oana Nicolescu, Mihaela Magdalena Mitache iD, Andrei Mitache, Adelina-Gabriela Niculescu iD, Dragos Garofil, Victor Dan Eugen Strambu, Bogdan Oancea iD, Marian Necula, Corneliu Ovidiu Vrancianu iD, Ioana Ruxandra Poiana, Adrian Radu Petru iD, Ana Maria Alexandra Stănescu iD

Diagnostics · 14.05.2026 · 16 (10) · 1498

DOI: 10.3390/diagnostics16101498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 14.05.2026. Verfasst von Oana Nicolescu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Research, Innovation and Digitalization through the National Recovery and Resilience Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Maintenance hemodialysis patients are particularly vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to evaluate clinical outcomes and identify admission laboratory biomarkers associated with in-hospital mortality in hospitalized hemodialysis patients with coronavirus disease 2019 (COVID-19).

Methods

We conducted a retrospective observational study including 130 adult hemodialysis patients with confirmed SARS-CoV-2 infection. Clinical characteristics and admission laboratory parameters were analyzed in relation to in-hospital outcomes using comparative, multivariable logistic regression, and receiver operating characteristic (ROC) curve analyses.

Results

The overall in-hospital mortality rate was 34.6%. The median age of the cohort was 66 years, with 64.6% male patients. Non-survivors showed significantly higher levels of inflammatory and tissue-injury markers, including C-reactive protein (CRP) (p < 0.001) and lactate dehydrogenase (LDH) (p < 0.001), together with lower serum albumin (p < 0.001), platelet count (p < 0.001), and lymphocyte levels (p = 0.03). In multivariable analysis, cardiovascular disease, respiratory disease, dyspnea, and ambulatory origin were independently associated with mortality. ROC analysis identified platelet count as the best individual predictor (area under the curve [AUC] = 0.767). An exploratory composite risk score demonstrated excellent discriminative performance (AUC = 0.902).

Conclusions

Admission inflammatory and hematological biomarkers are strongly associated with adverse outcomes in hospitalized hemodialysis patients with COVID-19. The integration of clinical and laboratory parameters into a composite risk score may improve early risk stratification and support clinical decision-making in this high-risk population.

Schlagwörter

Stichwörter der Autor:innen

COVID-19SARS-CoV-2biomarkerschronic kidney diseasedialysis managementinflammationmaintenance hemodialysismortalityprognosissurvival

Autor:innen und Institutionen

  • Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Faculty of Medicine, University Titu Maiorescu Bucharest, Gheorghe Petrașcu 67A, 031592 Bucharest, Romania.
  • Public Health Directorate, Avrig 72-74, District 2, 021578 Bucharest, Romania.
  • Research Institute of the University of Bucharest-ICUB, University of Bucharest, Șoseaua Panduri 90, District 5, 050663 Bucharest, Romania.
  • Department of Science and Engineering of Oxide Materials and Nanomaterials, National University of Science and Technology, POLITEHNICA, Splaiul Independenței 313, District 6, 060042 Bucharest, Romania.
  • Dr. Carol Davila Clinical Hospital of Nephrology, Calea Griviței 4, 010731 Bucharest, Romania.

ORCID-Profile: Mihaela Magdalena Mitache, Adelina-Gabriela Niculescu, Bogdan Oancea, Corneliu Ovidiu Vrancianu, Adrian Radu Petru, Ana Maria Alexandra Stănescu

Förderung

  • Ministry of Research, Innovation and Digitalization through the National Recovery and Resilience Plan

Zitieren

APA

Nicolescu, O., Mitache, M. M., Mitache, A., Niculescu, A. G., Garofil, D., Strambu, V. D. E., Oancea, B., Necula, M., Vrancianu, C. O., Poiana, I. R., Petru, A. R., & Stănescu, A. M. A. (2026). Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Hemodialysis Patients with COVID-19: A Retrospective Observational Study. Diagnostics, 16(10), 1498. https://doi.org/10.3390/diagnostics16101498

Vancouver

Nicolescu O, Mitache MM, Mitache A, Niculescu AG, Garofil D, Strambu VDE, et al. Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Hemodialysis Patients with COVID-19: A Retrospective Observational Study. Diagnostics. 2026;16(10):1498. doi:10.3390/diagnostics16101498

BibTeX
@article{Nicolescu2026,
  author = {Nicolescu, Oana and Mitache, Mihaela Magdalena and Mitache, Andrei and Niculescu, Adelina-Gabriela and Garofil, Dragos and Strambu, Victor Dan Eugen and Oancea, Bogdan and Necula, Marian and Vrancianu, Corneliu Ovidiu and Poiana, Ioana Ruxandra and Petru, Adrian Radu and Stănescu, Ana Maria Alexandra},
  title = {Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Hemodialysis Patients with COVID-19: A Retrospective Observational Study},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {1498},
  doi = {10.3390/diagnostics16101498}
}
Kostenlos starten →